Regencell Bioscience Holdings Ltd
For the period ended Jun 30, 2025. Filed Jun 30, 2025.
View on SEC.govAbout this filing
What a company based outside the US has published at home or sent to its shareholders. It is how many foreign companies share results and news between annual reports.
Jun 30, 2025 · Filed Jun 30, 2025
Use the contents to explore the available documents and sections.
Contents
Appointment of Independent Director
On June 30, 2025, the board of directors of Regencell Bioscience Holdings Limited, a company incorporated under the laws of the Cayman Islands (the “Company”), appointed Ms. Margaret Hoor Han Lo, as a director of the Company, effective the same day, to fill the vacancy resulting from the resignation of Mr. Paul J. Niewiadomski. Ms. Lo will also serve on the Company’s audit committee, compensation committee and nominating and corporate governance committee. Ms. Lo is a seasoned investor with over 30 years of extensive experience in real estate investments. She is also deeply committed to philanthropy, actively participating in various charitable initiatives and volunteer work. There is no family relationship between Ms. Lo and any of our other officers and directors.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.